153 related articles for article (PubMed ID: 30788205)
1. Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up.
Gutkin PM; Hiniker SM; Swetter SM; Reddy SA; Knox SJ
Cureus; 2018 Dec; 10(12):e3723. PubMed ID: 30788205
[TBL] [Abstract][Full Text] [Related]
2. A systemic complete response of metastatic melanoma to local radiation and immunotherapy.
Hiniker SM; Chen DS; Reddy S; Chang DT; Jones JC; Mollick JA; Swetter SM; Knox SJ
Transl Oncol; 2012 Dec; 5(6):404-7. PubMed ID: 23323154
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous long-lasting regression of multiple nevi and melanoma metastases after ipilimumab therapy.
Plaquevent M; Greliak A; Pinard C; Duval-Modeste AB; Joly P
Melanoma Res; 2019 Jun; 29(3):311-312. PubMed ID: 31026247
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy to Control Limited Melanoma Progression Following Ipilimumab.
Kropp LM; De Los Santos JF; McKee SB; Conry RM
J Immunother; 2016; 39(9):373-378. PubMed ID: 27662339
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiation therapy and immunotherapy.
Khalife M; Shahid K; Dabney RS; Phan AT
Clin Adv Hematol Oncol; 2019 Sep; 17(9):518-523. PubMed ID: 31549973
[TBL] [Abstract][Full Text] [Related]
6. Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition.
Blake Z; Marks DK; Gartrell RD; Hart T; Horton P; Cheng SK; Taback B; Horst BA; Saenger YM
J Immunother Cancer; 2018 Apr; 6(1):25. PubMed ID: 29622046
[TBL] [Abstract][Full Text] [Related]
7. Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review.
Schoenfeld JD; Mahadevan A; Floyd SR; Dyer MA; Catalano PJ; Alexander BM; McDermott DF; Kaplan ID
J Immunother Cancer; 2015; 3():50. PubMed ID: 26672895
[TBL] [Abstract][Full Text] [Related]
8. Durability of response in metastatic melanoma patients after combined treatment with radiation therapy and ipilimumab.
Sodji QH; Gutkin PM; Swetter SM; Reddy SA; Hiniker SM; Knox SJ
Melanoma Manag; 2020 Feb; 7(1):MMT36. PubMed ID: 32399174
[TBL] [Abstract][Full Text] [Related]
9. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab.
Chandra RA; Wilhite TJ; Balboni TA; Alexander BM; Spektor A; Ott PA; Ng AK; Hodi FS; Schoenfeld JD
Oncoimmunology; 2015 Nov; 4(11):e1046028. PubMed ID: 26451318
[TBL] [Abstract][Full Text] [Related]
10. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
11. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy.
Shi DD; Arnaout O; Bi WL; Buchbinder EI; Cagney DN; Insco ML; Liu D; Schoenfeld JD; Aizer AA
World Neurosurg; 2020 Jul; 139():226-231. PubMed ID: 32330622
[TBL] [Abstract][Full Text] [Related]
12. Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review.
Chicas-Sett R; Morales-Orue I; Rodriguez-Abreu D; Lara-Jimenez P
Clin Transl Radiat Oncol; 2018 Feb; 9():5-11. PubMed ID: 29594244
[TBL] [Abstract][Full Text] [Related]
13. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
Cohen-Inbar O; Shih HH; Xu Z; Schlesinger D; Sheehan JP
J Neurosurg; 2017 Nov; 127(5):1007-1014. PubMed ID: 28059663
[TBL] [Abstract][Full Text] [Related]
14. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
Grimaldi AM; Simeone E; Giannarelli D; Muto P; Falivene S; Borzillo V; Giugliano FM; Sandomenico F; Petrillo A; Curvietto M; Esposito A; Paone M; Palla M; Palmieri G; Caracò C; Ciliberto G; Mozzillo N; Ascierto PA
Oncoimmunology; 2014; 3():e28780. PubMed ID: 25083318
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
[TBL] [Abstract][Full Text] [Related]
16. Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses.
Welsh JW; Tang C; de Groot P; Naing A; Hess KR; Heymach JV; Papadimitrakopoulou VA; Cushman TR; Subbiah V; Chang JY; Simon GR; Ramapriyan R; Barsoumian HB; Menon H; Cortez MA; Massarelli E; Nguyen Q; Sharma P; Allison JP; Diab A; Verma V; Raju U; Shaaban SG; Dadu R; Cabanillas ME; Wang K; Anderson C; Gomez DR; Hahn S; Komaki R; Hong DS
Cancer Immunol Res; 2019 Dec; 7(12):1903-1909. PubMed ID: 31658994
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Abscopal Effect With Anti-PD1 Therapy in Patients With Metastatic Solid Tumors.
Ribeiro Gomes J; Schmerling RA; Haddad CK; Racy DJ; Ferrigno R; Gil E; Zanuncio P; Buzaid AC
J Immunother; 2016; 39(9):367-372. PubMed ID: 27741091
[TBL] [Abstract][Full Text] [Related]
18. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
19. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
20. Combined Immune Checkpoint Blockade and Stereotactic Ablative Radiotherapy Can Stimulate Response to Immunotherapy in Metastatic Melanoma: A Case Report.
Moran A; Azghadi S; Maverakis EM; Christensen S; Dyer BA
Cureus; 2019 Feb; 11(2):e4038. PubMed ID: 31011500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
